Welcome to our dedicated page for Venus Concept SEC filings (Ticker: VERO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Venus Concept Inc. filings document the company’s transition out of public reporting, including Form 25 removal of its common stock from Nasdaq listing and Form 15 suspension of Exchange Act reporting obligations. The records also cover its common stock registration status, holder count at deregistration, and related corporate-status disclosures.
Recent Form 8-K filings describe material agreements with Madryn-affiliated lenders, including Main Street Priority Loan consents, Bridge Loan amendments, liquidity-waiver provisions, interest-payment treatment, and a debt-to-equity exchange into Series Y Convertible Preferred Stock. Other reports disclose quarterly financial results and FDA 510(k) clearance for Venus NOVA, tying regulatory events to the company’s medical aesthetic device business.
Venus Concept Inc. is filing multiple post-effective amendments to its Form S-3 shelf registrations to deregister all unsold securities that had previously been registered. These changes are tied to the company’s decision to leave the U.S. public markets.
The board approved a plan on January 20, 2026 to voluntarily delist the company’s common stock from the Nasdaq Capital Market, suspend its duty to file periodic reports and other information with the SEC, and terminate the registration of its common stock under U.S. federal securities laws.
Venus Concept Inc. has filed post-effective amendments to multiple Form S-3 registration statements to deregister all unsold securities that were previously registered. This step follows the Board’s January 20, 2026 approval of a plan to voluntarily delist the company’s common stock from the Nasdaq Capital Market, suspend its SEC reporting obligations, and terminate the registration of its common stock under U.S. federal securities laws.
Venus Concept Inc. has filed post-effective amendments to multiple Form S-3 registration statements to deregister all unsold securities that were previously registered for potential sale. This step effectively removes the remaining capacity to issue or resell securities under those shelf registrations.
The company notes that its board of directors approved a plan on January 20, 2026 to voluntarily delist its common stock from the Nasdaq Capital Market, suspend its duty to file periodic reports with the SEC, and terminate the registration of its common stock under U.S. federal securities laws. The deregistration of unsold S-3 securities aligns with this broader move away from U.S. public market reporting status.
Venus Concept Inc. filed post-effective amendments to several Form S-3 registration statements to deregister all unsold securities that had previously been registered for potential sale. This step follows the board’s January 20, 2026 decision to voluntarily delist the company’s common stock from the Nasdaq Capital Market, suspend its obligation to file periodic reports with the SEC, and terminate the registration of its common stock under U.S. federal securities laws.